Glancy Binkow & Goldberg LLP Announces Investigation of Vitamin Shoppe, Inc.

LOS ANGELES--(BUSINESS WIRE)--

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of shareholders of Vitamin Shoppe, Inc. (“Vitamin Shoppe” or the “Company”) (VSI) concerning possible breaches of fiduciary duties by the Company or its fiduciaries. The investigation focuses on certain statements issued by Vitamin Shoppe between May 8, 2012 and February 25, 2013 concerning the Company’s business and financial prospects.

Vitamin Shoppe, through its subsidiaries, operates as a specialty retailer and direct marketer of nutritional products in the United States. The investigation is related to allegations that during the foregoing period the Company misrepresented or failed to disclose that Vitamin Shoppe’s business was being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements, that a new discount program was negatively impacting the Company’s sales growth, and that the Company was experiencing declining same-store sales trends.

If you purchased Vitamin Shoppe stock prior to May 8, 2012 and still hold those shares, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, by telephone at (310) 201-9150, or contact Gregory Linkh, Esquire, of Glancy Binkow & Goldberg LLP at 122 E. 42nd Street, Suite 2920, New York, New York 10168, at (212) 682-5340, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.